ALL Memory Studies Migraine Studies Multiple Sclerosis Studies Parkinson’s Studies Epilepsy Studies
  • Allergan Logo

    Allergan

    UbreIvy

    UbreIvy is an oral medication made for immediate treatment of migraines.

    Status: Completed

    FDA Approved

    Details
  • alder logo

    PROMISE

    Eptinezumab

    Eptinezumab (ALD403) is a CGRP antagonist for the prophylaxis of frequent episodic migraines.

    Status: Completed

    FDA Approved

    Details
  • Eli Lilly and Company logo white red

    TRIUMPH

    Emgality

    Emgality (galcanezumab) is a preventive treatment for migraines.

    Status: Completed

    FDA Approved

    Details